Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities
5.4 Pricing Analysis
Chapter 6. Global Inhalation Anesthesia Market, by Product
6.1 Introduction
6.2 Sevoflurane
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Isoflurane
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Desflurane
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Inhalation Anesthesia Market, by Application
7.1 Introduction
7.2 Induction
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Maintenance
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Inhalation Anesthesia Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Halocarbon Products Corporation
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Baxter
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Hikima Pharmaceuticals plc.
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Lunan Pharmaceutical Group Co. Ltd
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Piramal Enterprises Limited
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Jiangsu Hengrui Medicine Co. Ltd
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Fresenius Kabi AG
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 AbbVie Inc.
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Other
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the global inhalation anesthesia market
Chapter 12 Appendix
LIST OF TABLES
Table 1 Inhalation Anesthesia Market Synopsis, 2020-2027
Table 2 Inhalation Anesthesia Market Estimates and Forecast, 2020-2027(USD Million)
Table 3 Global Inhalation Anesthesia Market, by Region, 2020-2027(USD Million)
Table 4 Global Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 6 Global Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 7 North America: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 9 North America: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 10 US: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 12 US: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 13 Canada: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 15 Canada: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 16 South America: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 18 South America: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 19 Europe: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 21 Europe: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 22 Western Europe: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 24 Western Europe: Inhalation Anesthesia Market, by Application, 2020-2027(USD Million)
Table 25 Eastern Europe: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 27 Eastern Europe: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 28 Asia-Pacific: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 30 Asia-Pacific: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
Table 31 Middle East & Africa: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)
Table 33 Middle East & Africa: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Inhalation Anesthesia Market
Figure 3 Market Dynamics for Global Inhalation Anesthesia Market
Figure 4 Inhalation Anesthesia Market Share, by Product, 2020
Figure 6 Inhalation Anesthesia Market Share, Application, 2020
Figure 7 Inhalation Anesthesia Market Share, by Region, 2020
Figure 8 North America: Inhalation Anesthesia Market Share, by Country, 2020
Figure 9 Europe: Inhalation Anesthesia Market Share, by Country, 2020
Figure 10 Asia-Pacific: Inhalation Anesthesia Market Share, by Country, 2020
Figure 11 Middle East & Africa: Inhalation Anesthesia Market Share, by Region, 2020
Figure 12 Inhalation Anesthesia Market: Company Share Analysis, 2020 (%)
Figure 13 Halocarbon Products Corporation: Key Financials
Figure 14 Halocarbon Products Corporation: Segmental Revenue
Figure 15 Halocarbon Products Corporation: Geographical Revenue
Figure 16 Baxter: Key Financials
Figure 17 Baxter: Segmental Revenue
Figure 18 Baxter: Geographical Revenue
Figure 19 Hikima Pharmaceuticals plc.: Key Financials
Figure 20 Hikima Pharmaceuticals plc.: Segmental Revenue
Figure 21 Hikima Pharmaceuticals plc.: Geographical Revenue
Figure 22 Piramal Enterprises Limited.: Key Financials
Figure 23 Piramal Enterprises Limited: Segmental Revenue
Figure 24 Piramal Enterprises Limited: Geographical Revenue